Related Experiment Video

Updated: Aug 13, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy

Christian Tovar1, James Rosinski, Zoran Filipovic

  • 1Roche Research Center, Hoffmann-La Roche Inc., Nutley, NJ 07110, USA.

Proceedings of the National Academy of Sciences of the United States of America
|January 31, 2006
PubMed

Insights

Activating the p53 tumor suppressor pathway shows therapeutic potential. A drug called nutlin-3 preserved cell-cycle arrest but impaired apoptosis in many wild-type p53 tumors, indicating a new therapeutic strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • The p53 tumor suppressor is crucial for preventing cancer and remains functional in about half of human tumors.
  • Dysfunctional p53 signaling pathways can compromise its tumor-suppressive activity.
  • Targeting the p53 pathway offers potential therapeutic benefits for cancer treatment.

Purpose of the Study:

  • To investigate the downstream signaling of the p53 pathway in tumor cells using a small-molecule MDM2 antagonist.
  • To evaluate the efficacy of MDM2 inhibition in tumors with wild-type p53.
  • To identify potential biomarkers for predicting response to MDM2 antagonists.

Main Methods:

  • Utilized nutlin-3, a small-molecule MDM2 antagonist, to probe p53 signaling.
  • Assessed p53-dependent cell-cycle arrest and apoptosis in tumor-derived cell lines.
  • Performed gene array analysis to examine the expression of apoptosis-related genes.
  • Evaluated the in vitro and in vivo efficacy of nutlin-3 in cancer cells with varying MDM2 expression levels.

Main Results:

  • The cell-cycle arrest function of the p53 pathway was preserved in multiple tumor cell lines with wild-type p53.
  • Many of these cell lines exhibited a reduced capacity for p53-dependent apoptosis.
  • Gene array analysis indicated attenuated expression of apoptosis-related genes in these cells.
  • Cancer cells with MDM2 gene amplification showed the highest sensitivity to nutlin-3.
  • Nutlin-3 demonstrated efficacy in tumors with both amplified and normal MDM2 expression.

Conclusions:

  • MDM2 overexpression may be a key abnormality in the p53 pathway of some wild-type p53 tumors.
  • Antagonists targeting the p53-MDM2 interaction, like nutlin-3, show promise for treating a broad range of wild-type p53 tumors.
  • These findings suggest that patients with wild-type p53 tumors could benefit from therapies targeting the p53-MDM2 interaction.

More Related Videos

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...